Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts

Infection and Immunity

Volumn 76, Issue 8, 2008, Pages 3640-3650

  Arlen, Philip A ^a   Singleton, Michael ^a   Adamovicz, Jeffrey J ^b   Ding, Yi ^a   Davoodi Semiromi, Abdolreza ^a   Daniell, Henry ^a,c  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; FRACTION 1 VACCINE ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; CAF1 PROTEIN, YERSINIA PESTIS; HYBRID PROTEIN; IMMUNOGLOBULIN G; LCRV PROTEIN, YERSINIA; PLAGUE VACCINE; PORE FORMING CYTOTOXIC PROTEIN;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; CHLOROPLAST; COLONY FORMING UNIT; CONTROL GROUP; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HOMOPLASY; ILLUMINATION; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IN VIVO STUDY; LD 50; MOUSE; NONHUMAN; PLAGUE; PLANT CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; SWISS WEBSTER MOUSE; TRANSGENE; VACCINATION; YERSINIA PESTIS; ANIMAL; BACTERIAL COUNT; BIOSYNTHESIS; BLOOD; GENETICS; IMMUNIZATION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; SPLEEN; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL; TRANSGENIC PLANT;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CHLOROPLASTS; COLONY COUNT, MICROBIAL; FEMALE; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; MICE; PLAGUE; PLAGUE VACCINE; PLANTS, GENETICALLY MODIFIED; PORE FORMING CYTOTOXIC PROTEINS; RECOMBINANT FUSION PROTEINS; SPLEEN; SURVIVAL ANALYSIS; YERSINIA PESTIS;

EID: 48849104676     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00050-08     Document Type: Article

References (98)

1. Alvarez, M. L., H. L. Pinyerd, J. D. Crisantes, M. M. Rigano, J. Pinkhasov, A. M. Walmsley, H. S. Mason, and G. A. Cardineau. 2006. Plant-made subunit vaccine against pneumonic and bubonic plague is orally immunogenic in mice. Vaccine 24:2477-2490.
2. Anderson, G. W., Jr., D. G. Heath, C. R. Bolt, S. L. Welkos, and A. M. Friedlander. 1998. Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice. Am. J. Trop. Med. Hyg. 58:793-799.
3. Anderson, G. W., Jr., S. E. Leary, E. D. Williamson, R. W. Titball, S. L. Welkos, P. L. Worsham, and A. M. Friedlander. 1996. Recombinant V antigen protects mice against pneumonic and bubonic plague caused by Fl-capsule-positive and -negative strains of Yersinia pestis. Infect. Immun. 64:4580-4585.
4. Anderson, G. W., Jr., P. L. Worsham, C. R. Bolt, G. P. Andrews, S. L. Welkos, A. M. Friedlander, and J. P. Burans. 1997. Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis. Am. J. Trop. Med. Hyg. 56:471-473.
5. Anisimov, A. P., and K. K. Amoako. 2006. Treatment of plague: promising alternatives to antibiotics. J. Med. Microbiol. 55:1461-1475.
6. Anisimov, A. P., L. E. Lindler, and G. B. Pier. 2004. Intraspecific diversity of Yersinia pestis. Clin. Microbiol. Rev. 17:434-464.
7. Arntzen, C., S. Plotkin, and B. Dodet. 2005. Plant-derived vaccines and antibodies: potential and limitations. Vaccine 23:1753-1756.
8. Barnes, A. M., and T. J. Quan. 1992. Plague, p. 1285-1291. In S. Gorbach, J. Bartlett, and N. Blacklow (ed.), Infectious diseases. W. B. Saunders Company, Philadelphia, PA.
9. Benner, G. E., G. P. Andrews, W. R. Byrne, S. D. Strachan, A. K. Sample, D. G. Heath, and A. M. Friedlander. 1999. Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice. Infect. Immun. 67:1922-1928.
10. Chase, M. W. 1946. Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc. Exp. Biol. Med. 61:257-259.
11. Chebolu, S., and H. Daniell. 2007. Stable expression of Gal/GalNAc lectin of Entamoeba histolytica in transgenic chloroplasts and immunogenicity in mice towards vaccine development for amoebiasis. Plant Biotechnol. J. 5:230-239.
12. Collins, G. B., P. D. Legg, and M. C. Kasperbauer. 1974. Tobacco hybrid LAMD-609. Crop Sci. 14:72-80.
13. Cowan, C., A. V. Philipovskiy, C. R. Wulff-Strobel, Z. Ye, and S. C. Straley. 2005. Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis. Infect. Immun. 73:6127-6137.
14. Daniell, H. 2002. Molecular strategies for gene containment in transgenic crops. Nat. Biotechnol. 20:581-586.
15. Daniell, H. 2006. Production of biopharmaceuticals and vaccines in plants via the chloroplast genome. Biotechnol. J. 1:1071-1079.
16. Daniell, H. 2007. Transgene containment by maternal inheritance: effective or elusive? Proc. Natl. Acad. Sci. USA 104:6879-6880.
17. Daniell, H., S. Chebolu, S. Kumar, M. Singleton, and R. Falconer. 2005. Chloroplast-derived vaccine antigens and other therapeutic proteins. Vaccine 23:1779-1783.
18. Daniell, H., S.-B. Lee, T. Panchal, and P. O. Wiebe. 2001. Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts. J. Mol. Biol. 311:1001.
19. De Cosa, B., W. Moar, S, B. Lee, M. Miller, and H. Daniell. 2001. Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals. Nat. Biotechnol. 19:71-74.
20. Dhingra, A., A. R. Portis, Jr., and H. Daniell. 2004. Enhanced translation of a chloroplast-expressed RbcS gene restores small subunit levels and photosynthesis in nuclear RbcS antisense plants. Proc. Natl. Acad. Sci. USA 101:6315-6320.
21. Du, Y., R. Rosqvist, and A. Forsberg. 2002. Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis. Infect. Immun. 70:1453-1460.
22. Dufourmantel, N., B. Pelissier, F. Garcon, G. Peltier, J. M. Ferullo, and G. Tissot. 2004. Generation of fertile transplastomic soybean. Plant Mol. Biol 55:479-489.
23. Eyles, J. E., G. J. E. Sharp, E. D. Williamson, I. D. Spiers, and H. Oya Alpar. 1998. Intranasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse. Vaccine 16:698-707.
24. Eyles, J. E., I. D. Spiers, E. D. Williamson, and H. Oya Alpar. 1998. Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines. Vaccine 16:2000-2009.
25. Friedlander, A. M., S. L. Welkos, P. L. Worsham, G. P. Andrews, D. G. Heath, G. W. Anderson, Jr., M. L. Pitt, J. Estep, and K. Davis. 1995. Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin. Infect. Dis. 21(Suppl. 2):S178-S181.
26. Galimand, M., E. Carniel, and P. Courvalin. 2006. Resistance of Yersinia pestis to antimicrobial agents. Antimicrob. Agents Chemother. 50:3233-3236.
27. Galimand, M., A. Guiyoule, G. Gerbaud, B. Rasoamanana, S. Chanteau, E. Carniel, and P. Courvalin. 1997. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N. Engl. J. Med. 337:677-681.
28. Garmory, H. S., K. F. Griffin, K. A. Brown, and R. W. Titball. 2003. Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague. Vaccine 21:3051-3057.
29. Glynn, A., L. C. Freytag, and J. D. Clements. 2005. Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens. Vaccine 23:1957-1965.
30. Glynn, A., C. J. Roy, B. S. Powell, J. J. Adamovicz, L. C. Freytag, and J. D. Clements. 2005. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens. Infect. Immun. 73:5256-5261.
31. Greenfield, R. A., and M. S. Bronze. 2003. Prevention and treatment of bacterial diseases caused by bacterial bioterrorism threat agents. Drug Discov. Today 8:881-888.
32. Gupta, R. K., B. E. Rost, E. Relyveld, and G. R. Siber. 1995. Adjuvant properties of aluminum and calcium compounds. Pharm. Biotechnol. 6:229-248.
33. Guyton, A. C. 1947. Measurement of the respiratory volumes of laboratory animals. Am. J. Physiol. 150:70-77.
34. Hamilton, S. R., J. H. Yardley, and G. D. Brown. 1979. Suppression of local intestinal immunoglobulin A immune response to cholera toxin by subcutaneous administration of cholera toxoids. Infect. Immun. 24:422-426.
35. Heath, D. G., G. W. Anderson, J. M. Mauro, S. L. Welkos, G. P. Andrews, J. Adamovicz, and A. M. Friedlander. 1998. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 16:1131-1137.
36. Heine, H. S., A. Louie, F. Sorgel, J. Bassett, L. Miller, L. J. Sullivan, M. Kinzig-Schippers, and G. L. Drusano. 2007. Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague. J. Infect. Dis. 196:782-787.
37. Hill, J., J. E. Eyles, S. J. Elvin, G. D. Healey, R. A. Lukaszewski, and R. W. Titball. 2006. Administration of antibody to the lung protects mice against pneumonic plague. Infect. Immun. 74:3068-3070.
38. Hill, J., S. E. Leary, K. F. Griffin, E. D. Williamson, and R. W. Titball. 1997. Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization. Infect. Immun. 65:4476-4482.
39. Hinnebusch, B. J., M.-L. Rosso, T. G. Schwan, and E. Carniel. 2002. High-frequency conjugative transfer of antibiotic resistance genes to Yersinia pestis in the flea midgut. Mol. Microbiol. 46:349-354.
40. Holmgren, J., and C. Czerkinsky. 2005. Mucosal immunity and vaccines. Nat. Med. 11(4 Suppl.):S45-S53.
41. Hurtle, W., L. Lindler, W. Fan, D. Shoemaker, E. Henchal, and D. Norwood. 2003. Detection and identification of ciprofloxacin-resistant Yersinia pestis by denaturing high-performance liquid chromatography. J. Clin. Microbiol. 41:3273-3283.
42. Inglesby, T. V., D. T. Dennis, D. A. Henderson, J. G. Bartlett, M. S. Ascher, E. Eitzen, A. D. Fine, A. M. Friedlander, J. Hauer, J. F. Koerner, M. Lavton, J. McDade, M. T. Osterholm, T. O'Toole, G. Parker, T. M. Perl, P. K. Russell, M. Schoch-Spana, and K. Tonat. 2000. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 283:2281-2290.
43. Jones, T., J. J. Adamovicz, S. L. Cyr, C. R. Bolt, N. Bellerose, L. M. Pitt, G. H. Lowell, and D. S. Burt. 2006. Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection. Vaccine 24:1625-1632.
44. Kamarajugadda, S., and H. Daniell. 2006. Chloroplast-derived anthrax and other vaccine antigens: their immunogenic and immunoprotective properties. Expert Rev. Vaccines 5:839-849.
45. Kanamoto, H., A. Yamashita, H. Asao, S. Okumura, H. Takase, M. Hattori, A. Yokota, and K. Tomizawa. 2006. Efficient and stable transformation of Lactuca sativa L. cv. Cisco (lettuce) plastids. Transgenic Res. 15:205-217.
46. Koster, F. T., and N. F. Pierce. 1983. Parenteral immunization causes antigen-specific cell-mediated suppression of an intestinal IgA response. J. Immunol. 131:115-119.
47. Koya, V., M. Moayeri, S. H. Leppla, and H. Daniell. 2005. Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge. Infect. Immun. 73:8266-8274.
48. Kumar, S., and H. Daniell. 2004. Engineering the chloroplast genome for hyperexpression of human therapeutic proteins and vaccine antigens. Methods Mol. Biol. 267:365-383.
49. Kumar, S., A. Dhingra, and H. Daniell. 2004. Plastid-expressed betaine aldehyde dehydrogenase gene in carrot cultured cells, roots, and leaves confers enhanced salt tolerance. Plant Physiol. 136:2843-2854.
50. Lavelle, E. C., and D. T. O'Hagan. 2006. Delivery systems and adjuvants for oral vaccines. Expert Opin. Drug Deliv. 3:747-762.
51. Leary, S. E., E. D. Williamson, K. F. Griffin, P. Russell, S. M. Eley, and R. W. Titball. 1995. Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague. Infect. Immun. 63:2854-2858.
52. Limaye, A., V. Koya, M. Samsam, and H. Daniell. 2006. Receptor-mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chloroplasts into the mouse circulatory system. FASEB J. 20:959-961.
53. Lindblad, E. B. 2004. Aluminium adjuvants - in retrospect and prospect. Vaccine 22:3658-3668.
54. MacDonald, T. T. 1982. Enhancement and suppression of the Peyer's patch immune response by systemic priming. Clin. Exp. Immunol. 49:441-448.
55. Mattingly, J. A., and B. H. Waksman. 1978. Immunologic suppression after oral administration of antigen. I. Specific suppressor cells formed in rat Peyer's patches after oral administration of sheep erythrocytes and their systemic migration. J. Immunol. 121:1878-1883.
56. Mestecky, J., and J. R. McGhee. 1987. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol. 40:153-245.
57. Mett, V., J. Lyons, K. Musiychuk, J. A. Chichester, T. Brasil, R. Couch, R. Sherwood, G. A. Palmer, S. J. Streatfield, and V. Yusibov. 2007. A plant-produced plague vaccine candidate confers protection to monkeys. Vaccine 25:3014-3017.
58. Meyer, K. F., J. A. Hightower, and F. R. McCrumb. 1974. Plague immunization. VI. Vaccination with the fraction I antigen of Yersinia pestis. J. Infect. Dis. 129(Suppl.):S41-S45.
59. Molina, A., S. Hervas-Stubbs, H. Daniell, A. M. Mingo-Castel, and J. Veramendi. 2004. High-yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts. Plant Biotechnol. J. 2:141-153.
60. Morton, M., H. S. Garmory, S. D. Perkins, A. M. O'Dowd, K. F. Griffin, A. K. Turner, A. M. Bennett, and R. W. Titball. 2004. A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice. Vaccine 22:2524-2532.
61. Motin, V. L., R. Nakajima, G. B. Smirnov, and R. R. Brubaker. 1994. Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide. Infect. Immun. 62:4192-4201.
62. Perry, R. D., and J. D. Fetherston. 1997. Yersinia pestis - etiologic agent of plague. Clin. Microbiol. Rev. 10:35-66.
63. Pettersson, J., A. Holmstrom, J. Hill, S. Leary, E. Frithz-Lindsten, A. von Euler-Matell, E. Carlsson, R. Titball, A. Forsberg, and H. Wolf-Watz. 1999. The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation. Mol. Microbiol. 32:961-976.
64. Philipovskiy, A. V., C. Cowan, C. R. Wulff-Strobel, S. H. Burnett, E. J. Kerschen, D. A. Cohen, A. M. Kaplan, and S. C. Straley. 2005. Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis. Infect. Immun. 73:1532-1542.
65. Pollitzer, R. 1954. Plague. WHO Monogr. Ser. 22:1-698.
66. Powell, B. S., G. P. Andrews, J. T. Enama, S. Jendrek, C. Bolt, P. Worsham, J. K. Pullen, W. Ribot, H. Hines, L. Smith, D. G. Heath, and J. J. Adamovicz. 2005. Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague. Biotechnol. Prog. 21:1490-1510.
67. Quesada-Vargas, T., O. N. Ruiz, and H. Daniell. 2005. Characterization of heterologous multigene operons in transgenic chloroplasts: transcription, processing, and translation. Plant Physiol. 138:1746-1762.
68. Rodrigues, C. G., C. M. Carneiro, C. T. Barbosa, and R. A. Nogueira. 1992. Antigen F1 from Yersinia pestis forms aqueous channels in lipid bilayer membranes. Braz. J. Med. Biol. Res. 25:75-79.
69. Roggenkamp, A., A. M. Geiger, L. Leitritz, A. Kessler, and J. Heesemann. 1997. Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen. Infect. Immun. 65:446-451.
70. Ruhlman, T., R. Ahangari, A. Devine, M. Samsam, and H. Daniell. 2007. Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts - oral administration protects against development of insulitis in non-obese diabetic mice. Plant Biotechnol. J. 5:495-510.
71. Ruiz, O. N., and H. Daniell. 2005. Engineering cytoplasmic male sterility via the chloroplast genome by expression of β-ketothiolase. Plant Physiol. 138:1232-1246.
72. Rydell, N., and I. Sjoholm. 2004. Oral vaccination against diphtheria using polyacryl starch microparticles as adjuvant. Vaccine 22:1265-1274.
73. Sabhnani, L., M. Manocha, K. Sridevi, D. Shashikiran, R. Rayanade, and D. N. Rao. 2003. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles. FEMS Immunol. Med. Microbiol. 38:215-229.
74. Sabhnani, L., and D. N. Rao. 2000. Identification of immunodominant epitope of F1 antigen of Yersinia pestis. FEMS Immunol. Med. Microbiol. 27:155-162.
75. Santi, L., A. Giritch, C. J. Roy, S. Marillonnet, V. Klimyuk, Y. Gleba, R. Webb, C. J. Arntzen, and H. S. Mason. 2006. Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system. Proc. Natl. Acad. Sci. USA 103:861-866.
76. Simpson, W. J., R. E. Thomas, and T. G. Schwan. 1990. Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice. Am. J. Trop. Med. Hyg. 43:389-396.
77. Sing, A., D. Rost, N. Tvardovskaia, A Roggenkamp, A. Wiedemann, C. J. Kirschning, M. Aepfelbacher, and J. Heesemann. 2002. Yersinia V-antigen exploits Toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J. Exp. Med. 196:1017-1024.
78. Snapper, C. M., F. D. Finkelman, and W. E. Paul. 1988. Differential regulation of IgG1 and IgE synthesis by interleukin 4. J. Exp. Med. 167:183-196.
79. 2+ in Yersinia pestis include structural genes for outer membrane proteins. Infect. Immun. 51:445-454.
80. Streatfield, S. J. 2007. Approaches to achieve high-level heterologous protein production in plants. Plant Biotechnol. J. 5:2-15.
81. Taylor, V. L., R. W. Titball, and P. C. F. Oyston. 2005. Oral immunization with a dam mutant of Yersinia pseudotuberculosis protects against plague. Microbiology 151:1919-1926.
82. Titball, R. W., and E. D. Williamson. 2001. Vaccination against bubonic and pneumonic plague. Vaccine 19:4175-4184.
83. Tregoning, J. S., P. Nixon, H. Kuroda, Z. Svab, S. Clare, F. Bowe, N. Fairweather, J. Ytterberg, K. J. van Wijk, G. Dougan, and P. Maliga. 2003. Expression of tetanus toxin fragment C in tobacco chloroplasts. Nucleic Acids Res. 31:1174-1179.
84. Une, T., and R. R. Brubaker. 1984. Roles of V antigen in promoting virulence and immunity in yersiniae. J. Immunol. 133:2226-2230.
85. Verma, D., and H. Daniell. 2007. Chloroplast vector systems for biotechnology applications. Plant Physiol. 145:1129-1143.
86. Verma, D., N. P. Samson, V. Koya, and H. Daniell. 2008. A protocol for expression of foreign genes in chloroplasts. Nat. Protoc. 3:739-758.
87. Watson, J., V. Koya, S. H. Leppla, and H. Daniell. 2004. Expression of Bacillus anthracis protective antigen in transgenic chloroplasts of tobacco, a non-food/feed crop. Vaccine 22:4374-4384.
88. Weeks, S., J. Hill, A. Friedlander, and S. Welkos. 2002. Anti-V antigen antibody protects macrophages from Yersinia pestis-induced cell death and promotes phagocytosis. Microb. Pathog. 32:227-237.
89. Williams, R. C., Jr., H. Gewurz, and P. G. Quie. 1972. Effects of fraction I from Yersinia pestis on phagocytosis in vitro. J. Infect. Dis. 126:235-241.
90. Williamson, E. D. 2001. Plague vaccine research and development. J. Appl. Microbiol. 91:606-608.
91. Williamson, E. D., H. C. Flick-Smith, C. LeButt, C. A. Rowland, S. M. Jones, E. L. Waters, R. J. Gwyther, J. Miller, P. J. Packer, and M. Irving. 2005. Human immune response to a plague vaccine comprising recombinant F1 and V antigens. Infect. Immun. 73:3598-3608.
92. Williamson, E. D., H. C. Flick-Smith, E. Waters, J. Miller, I. Hodgson, C. S. Le Butt, and J. Hill. 2007. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates. Microb. Pathog. 42:11-21.
93. Williamson, E. D., G. J. E. Sharp, S. M. Eley, P. M. Vesey, T. C. Pepper, R. W. Titball, and H. O. Alpar. 1996. Local and systemic immune response to a microencapsulated sub-unit vaccine for plague. Vaccine 14:1613-1619.
94. Williamson, E. D., and R. W. Titball. 2002. Vaccines against dangerous pathogens. Br. Med. Bull 62:163-173.
95. Williamson, E. D., P. M. Vesey, K. J. Gillhespy, S. M. Eley, M. Green, and R. W. Titball. 1999. An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model. Clin. Exp. Immunol. 116:107- 114.
96. Yang, X., B. J. Hinnebusch, T. Trunkle, C. M. Bosio, Z. Suo, M. Tighe, A. Harmsen, T. Becker, K. Crist, N. Walters, R. Avci, and D. W. Pascual. 2007. Oral vaccination with Salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague. J. Immunol. 178:1059-1067.
97. Yersin, A. 1895. La peste bubonique (deuxième note). Ann. Inst. Pasteur. 9:589-592.
98. Zav'yalov, V., A. Denesyuk, G. Zav'yalova, and T. Korpela. 1995. Molecular modeling of the steric structure of the envelope F1 antigen of Yersinia pestis. Immunol. Lett. 45:19-22.